Impact of glaucoma on outcomes after epiretinal membrane surgery. a pairwise and post-hoc single-arm meta-analysis

Read full text Summarise with VIRAT
Authors: Raphaela Masetto Cadide Fuganti, Tiago Nelson de Oliveira Rassi, Maikon V. Fuganti, Neeran Narainswami, Jorge Carlos Pessoa Rocha, Sunir Garg, Maurício Maia, Antônio Marcelo Barbante Casella, Raphaela Masetto Cadide Fuganti, Antônio Marcelo Barbante Casella
Cited by: 0
References: 22

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

To evaluate whether glaucoma modifies functional, anatomical, and intraocular pressure outcomes after pars plana vitrectomy (PPV) with internal limiting membrane (ILM) peeling for idiopathic epiretinal membrane (ERM). PubMed, Embase, and Cochrane Library were searched through April 27, 2025, for comparative studies of PPV with ILM peeling in glaucomatous versus non-glaucomatous eyes. Primary outcome was the change (Δ) in best-corrected visual acuity (BCVA); secondary outcomes were changes (Δ) in central macular thickness (CMT), intraocular pressure (IOP), and number of glaucoma medications. Risk of bias was assessed with ROBINS-I and certainty of evidence with GRADE. A post-hoc single-arm synthesis summarized outcomes in glaucomatous eyes. PROSPERO registration: CRD420251041680. Six studies (779 eyes: 256 glaucomatous, 523 non-glaucomatous) contributed to the pairwise meta-analysis, and three additional studies (325 glaucomatous eyes) informed single-arm data. Non-glaucomatous eyes achieved greater BCVA improvement (mean difference − 6.95 ETDRS letters; 95% CI − 11.54 to − 2.35; p < 0.01) and larger CMT reduction after outlier removal (+ 39.50 μm; 95% CI 11.48 to 67.53; p = 0.006). Glaucomatous eyes still improved significantly (BCVA + 10.03 ETDRS letters; CMT − 102.05 μm), with stable IOP (Δ + 0.64 mmHg; p = 0.12) but increased medication use (+ 0.61 drops; p < 0.001). Follow-up ranged from 6 to 12 months, and overall evidence certainty was high. Glaucoma attenuates, but does not eliminate, the visual and anatomical benefits of ERM surgery. However, central visual field safety cannot be guaranteed, particularly in moderate to advanced disease. Careful postoperative glaucoma monitoring and individualized management are recommended.

Fields of Study & Subjects

Retinal and Macular Surgery Retinal Diseases and Treatments Glaucoma and retinal disorders

Publication details

Journal / source
Graefe s Archive for Clinical and Experimental Ophthalmology
Volume
264
Issue
7
Pages
1949–1961
Publication date
26 March 2026
Language
EN